CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 106  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0742
LYS 10.0064
GLU 20.0335
LEU 30.0742
ARG 40.0232
CYS 50.0137
GLN 60.0126
CYS 70.0490
ILE 80.0281
LYS 90.0135
THR 100.0184
TYR 110.0116
SER 120.0059
LYS 130.0254
PRO 140.0324
PHE 150.0245
HIS 160.0278
PRO 170.0143
LYS 180.0236
PHE 190.0049
ILE 200.0137
LYS 210.0311
GLU 220.0206
LEU 230.0151
ARG 240.0136
VAL 250.0126
ILE 260.0059
GLU 270.0294
SER 280.0068
GLY 290.0065
PRO 300.0304
HIS 310.0200
CYS 320.0047
ALA 330.0192
ASN 340.0142
THR 350.0065
GLU 360.0089
ILE 370.0074
ILE 380.0156
VAL 390.0116
LYS 400.0058
LEU 410.0111
SER 420.0236
ASP 430.0356
GLY 440.0290
ARG 450.0323
GLU 460.0222
LEU 470.0202
CYS 480.0144
LEU 490.0118
ASP 500.0136
PRO 510.0142
LYS 520.0274
GLU 530.0079
ASN 540.0086
TRP 550.0088
VAL 560.0058
GLN 570.0029
ARG 580.0144
VAL 590.0059
VAL 600.0199
GLU 610.0344
LYS 620.0221
PHE 630.0151
LEU 640.0162
LYS 650.0113
ARG 660.0207
ALA 670.0150
GLU 680.0235
ASN 690.0606

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.